August 8th, 2016: Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis
Jody Smith joins with other ME voices in honor of Understanding and Remembrance Day for Severe Myalgic Encephalomyelitis.
Discuss the article on the Forums.

If the Norway Rituximab trials are a success - Will it be available worldwide?

Discussion in 'Rituximab: News and Research' started by Apple, May 24, 2017.

  1. Apple

    Apple Senior Member

    Possibly to soon to discuss this, but what do you think?

    Do you think each country will want to do individual trials like the UK to try and replicate it or do you think that it will become widely available as a treatment around the world?

    What are the views where you are?
    Last edited: May 24, 2017
  2. alex3619

    alex3619 Senior Member

    Logan, Queensland, Australia
    I am almost sure there will be a fight to make it available globally. That is where advocacy will become very important. This treatment is not cheap, and much will depend on whether or not its possible to determine who will go into long term remission rather than a few months of remission or symptom reduction, or no remission or symptom reduction.

    In Australia I think Rituximab use is regulated. We will have to convince the regulators.
    TrixieStix, AndyPR, L'engle and 5 others like this.
  3. BurnA

    BurnA Senior Member

    TrixieStix, AndyPR and MEMum like this.
  4. dannybex

    dannybex Senior Member

    I attended a lecture a couple years ago given by Dr. David Bell, who while excited about the possibilities, thought that even if it did show effectiveness in a subgroup, would probably take 20 years before it's approved.
    ballard likes this.
  5. BurnA

    BurnA Senior Member

    Sorry but I think that's baloney.
    TrixieStix, Valentijn, Hugo and 5 others like this.
  6. Ysabelle-S

    Ysabelle-S Highly Vexatious

    I doubt it will take twenty years to be approved, unless the BPS crowd manage to colonise the global healthcare systems. If the drug companies see this drug is helpful, I think they will be looking at how they can cash in. I view them through somewhat cynical eyes - I think profits are their main language, and there are a lot of people with this illness globally. But if Rituximab phase three trial does pan out well, they might be looking to develop a new version of the drug - did they not do this with MS? Of course, developing new drugs will take longer, so it would be helpful to start with what is being tested now, assuming the results of the phase two Cyclophosphamide and phase three Rituximab are successful.
  7. BurnA

    BurnA Senior Member

    There are already new B cell depletion drugs being developed. B cell depletion is not specific to ME, so the results of the trial will have no impact on this.

    If we want specific ME drugs we need to wait until we understand the illness more. But that is going off topic.

    Rituximab is off patent now and any approval filing will not be submitted by a drug company ( they didn't perform the trial) so it's a very unique situation.
    Ellie_Finesse, cfs6691, MEMum and 4 others like this.
  8. charles shepherd

    charles shepherd Senior Member

    Demonstrating both safety and efficacy in one large and well conducted phase clinical 3 trial in another country will NOT be enough to persuade the authorities here in the UK to grant a product license for the use of rituximab in ME/CFS

    So you are not going to see NICE adding rituximab to its list of recommended treatments for ME/CFS (i.e. CBT and GET) following publication of the results from Norway - which will hopefully occur before the middle of 2018

    If the Norway results are positive, and other independent trials confirm safety and efficacy (which is why I have argued that the MRC should look at funding a large phase 3 clinical trial here in the UK) then the situation will change

    But this will take time and if I was a betting man I would not put any money on rituximab being made available here in the UK for at least 4 years

    If the results are negative, it's difficult to see interest in this drug being maintained

    Morrow, Ellie_Finesse, MEMum and 8 others like this.
  9. Marky90

    Marky90 Science breeds knowledge, opinion breeds ignorance

    Given the premise that it showed effect, that`s ridiculous though. And knowing the U.K on this area, it would probably take even longer. Rituximab is a safe drug, it`s been tested loads of times in other conditions. Theres no need for 3-4 phase 3`s
    Ellie_Finesse, MEMum, Jo Best and 6 others like this.
  10. JamBob

    JamBob Senior Member

    How likely is it that other countries like France, Belgium and the Netherlands would make the drug available in clinics on the basis of the Norwegian results?

    I could travel somewhere accessible by train but am unable to fly anywhere which rules out Norway.
    Ellie_Finesse, MEMum and justy like this.
  11. dreampop

    dreampop Senior Member

    20 years is an absurd, out-of-touch estimate. Certainly the resistance in the medical community to treat a presumed not serious condition like CFS with a serious drug like Ritux will be the problem. I guess this question is a little confusing because the drug already is widely available, but is not approved by any insurance to treat CFS. AFAI coverage for M.S. drugs isn't even even great or 100%, so I would expect insurance would only cover a portion. The insurance argument would demand another phase III trial, so probably at least 3 years plus a year of bureaucracy. So 4-5 years. I believe it will be tested in the NIH in-house study, Nath said he wants to try drugs in the second phase and Ritux is the only drug with convincing evidence behind it (given the thread's assumptions).

    Another angle is "biomarker" or convincing test for CFS probably plays a role in how willing insurance will be to cover a drug for fatigue. They, and we, don't want somebody who has mild chronic fatigue but not CFS on a drug like Ritux after only 6 months. I'm not sure how the logistics of it would work. This is in the U.S., I have no idea how a socialist country would handle it. I'm sure 4-5 years is a good guess for a country like Norway, but the U.K. could be a lot looonger.

    In the short term, I suspect if it works we will be making a trip to a country to take it cheaply and travel there every 6 months or so. I have no idea what the risks or with JVC past a few years, though.

    Actually, that's a good question - if the drug works, and say works for me, is it safe to take for a decade until something better comes along? Does anyone know who would have a good answer to that question.
    MEMum, Rvanson and Snow Leopard like this.
  12. Riley

    Riley Senior Member

    @Jonathan Edwards
    MEMum likes this.
  13. Jesse2233

    Jesse2233 Senior Member

    Southern California
    There are RA patients who take the drug for a decade
    MEMum, Sancar, Rvanson and 2 others like this.
  14. Snow Leopard

    Snow Leopard Hibernating

    South Australia
    Since the drug has already been approved for other conditions, there is already an abundance of safety data from the many other trials conducted.

    Large trials are not needed to demonstrate efficacy (unless the effect size is very weak), they are only needed to demonstrate safety, since adverse effects are rarer than positive effects. There does however need to be independent replications.

    Three double blinded studies along with the auxiliary unblinded studies will provide compelling evidence, if they all have similar results. (The already conducted small Norwegian study, the larger Norwegian study and the small UK study).

    Of course the discovery some sort of objective marker associated with improvement will seal the deal, more so than another larger trial.

    That said, it will be great if there was another larger study, but I doubt anyone is willing to fund it until at least the larger Norwegian trial results are published (and positive).
  15. Valentijn

    Valentijn Senior Member

    I don't think there are any clinics in the Netherlands that would be qualified to administer it. It would probably have to happen in a hospital.
    MEMum and JamBob like this.
  16. Demepivo

    Demepivo Dolores Abernathy

    @charles shepherd Thanks for the Rituximab info?

    I know you're doing your best but do the MRC pay any attention the MEA or MERUK?

    Commentators here aren't exactly enamoured with the self interest shown by CMRC members . :mad::mad::mad::mad:
    MEMum and ukxmrv like this.
  17. Pendergast

    Pendergast Spain

    I think another issue is that if a government approves this drug, or some hospitals or "M.E. specialists" give it to us, after having mistreated and ingnored us for so long time, then they have to recognize the seriousness of this illness and the negligence they have committed with they denialist and "go and do exercise"-like attitude.

    At least I don't imagine my spanish health minister asking forgiveness to us like the Norwegian did...

    So it's not only a scientific question, but political too.

    On the other hand, if the trial is successful ( we desperately need it to be, but maybe it isn't) I think some Drs who are now waiting for the results of the trial, will consider trying Ritux on their ME patients, even if it's only in some local hospitals and not worldwide. And that will be good anyway.

    But in any case, I hope every day that Ron Davis et al find some answers soon. To have safer alternatives if the Ritux trial is successful and not to despair if it isn't.
    MEMum, Jan, Sancar and 4 others like this.
  18. Rvanson

    Rvanson Senior Member

    Likely be the same way in the US, if US doctors start taking ME seriously, that is.
  19. charles shepherd

    charles shepherd Senior Member

    The simple answer is yes - but we do not always get what we ask for (e.g. another round of ring fenced money for ME/CFS research)

    I have fairly regular contact that involves various people who are involved with both ME/CFS at the MRC and the MRC Neurosciences Board (where most ME/CFS research sits)

    In fact, I will be at a meeting at the MRC next week that is bringing tougher various groups, including NIH, who are involved in funding ME/CFS research

  20. Jo Best

    Jo Best Senior Member

    Positive political action by patients/parents got the last round of ring fenced money for ME/CFS research from the MRC.
    The 'instigating' patient (Jan Laverick) is featured in the regional ITV news report:

    The short debate in Westminster Hall :

    The Early Day Motion (778) that earned the Feb 2011 debate:

    A few months later (July 2011) Jan Laverick co-founded the 'Let's Do It for ME!' campaign to help raise awareness for the plan by UK charity Invest in ME (Research) to establish a centre of excellence for translational biomedical research and patient care for myalgic encephalomyelitis, and to raise funds for the research (which got underway in 2013)

    In June 2013 Invest in ME Research announced their plans for the UK Rituximab Trial.

    NIH will be represented in London next week for the 2nd year running by Dr. Vicky Whittemore (as well as Dr. Beth Unger from the CDC this year) at the 12th Invest in ME Conference and 7th Biomedical Research into ME Colloquium organised and hosted by UK charity Invest in ME Research.
    Izola, MEMum, mango and 1 other person like this.

See more popular forum discussions.

Share This Page